|
There is new hope for managing osteoporosis. A laboratory blood test,
called Ostase, which can accurately measure how well bone is responding
to hormone replacement therapy. The test measures the amount of a
specific bone alkaline phosphatase (BAP) in the blood and gives doctors
a clear indication of whether the therapy is successful in reducing bone
loss. It is the only blood test available in the U.S. to aid in the
management of postmenopausal osteoporosis.
Traditional Ostase helps document the success of therapy after only six
months. Bone mineral density tests, on the other hand, require a minimum
of twelve to twenty-four months on therapy to detect changes in bone.
With Ostase, you can see accurate, measurable results in less than half
the time required of bone mineral density testing.
|
